Citation: T. Priestley et al., L-687,414, A LOW EFFICACY NMDA RECEPTOR GLYCINE SITE PARTIAL AGONIST IN-VITRO, DOES NOT PREVENT HIPPOCAMPAL LTP IN-VIVO AT PLASMA-LEVELS KNOWN TO BE NEUROPROTECTIVE, British Journal of Pharmacology, 124(8), 1998, pp. 1767-1773
Authors:
CHALMERSREDMAN RME
PRIESTLEY T
KEMP JA
FINE A
Citation: Rme. Chalmersredman et al., IN-VITRO PROPAGATION AND INDUCIBLE DIFFERENTIATION OF MULTIPOTENTIAL PROGENITOR CELLS FROM HUMAN FETAL BRAIN, Neuroscience, 76(4), 1997, pp. 1121-1128
Citation: P. Laughton et al., INDIVIDUAL NEURONS ISOLATED FROM 4 REGIONS OF RAT-BRAIN EXPRESS MIXEDPOPULATIONS OF NMDA RECEPTOR SUBTYPES, British Journal of Pharmacology, 120, 1997, pp. 237-237
Citation: T. Priestley et Gw. Evans, RESIDENT PERCEPTIONS OF A NEARBY ELECTRIC TRANSMISSION-LINE, Journal of environmental psychology, 16(1), 1996, pp. 65-74
Citation: T. Priestley et al., TIME-DEPENDENT CHANGES IN NMDA RECEPTOR EXPRESSION IN NEURONS CULTURED FROM RAT-BRAIN, Molecular brain research, 40(2), 1996, pp. 271-274
Authors:
PRIESTLEY T
LAUGHTON P
MACAULAY AJ
HILL RG
KEMP JA
Citation: T. Priestley et al., ELECTROPHYSIOLOGICAL CHARACTERIZATION OF THE ANTAGONIST PROPERTIES OF2 NOVEL NMDA RECEPTOR GLYCINE SITE ANTAGONISTS, L-695,902 AND L-701,324, Neuropharmacology, 35(11), 1996, pp. 1573-1581
Citation: T. Priestley et al., NMDA RECEPTOR SUBTYPES EXPRESSED BY RAT CULTURED CORTICAL-NEURONS CHANGE WITH TIME IN-VITRO, British Journal of Pharmacology, 117, 1996, pp. 337-337
Authors:
HARPER SJ
MACAULAY AJ
HILL RG
PRIESTLEY T
Citation: Sj. Harper et al., THE EFFECTS OF INSULIN-LIKE GROWTH-FACTOR ANALOGS ON SURVIVAL OF CULTURED CEREBRAL-CORTEX AND CEREBELLAR GRANULE NEURONS, Brain research, 709(2), 1996, pp. 303-310
Authors:
PRIESTLEY T
LAUGHTON P
MYERS J
LEBOURDELLES B
KERBY J
WHITING PJ
Citation: T. Priestley et al., PHARMACOLOGICAL PROPERTIES OF RECOMBINANT HUMAN N-METHYL-D-ASPARTATE RECEPTORS COMPRISING NR1A NR2A AND NR1A/NR2B SUBUNIT ASSEMBLIES EXPRESSED IN PERMANENTLY TRANSFECTED MOUSE FIBROBLAST CELLS/, Molecular pharmacology, 48(5), 1995, pp. 841-848
Authors:
DANKS P
LEBOURDELLES B
MYERS J
WHITING P
KEMP JA
PRIESTLEY T
Citation: P. Danks et al., PHARMACOLOGICAL PROFILE OF RECOMBINANT HUMAN NR1A PLUS NR2A AND NATIVE RAT CEREBELLAR GRANULE CELL NMDA RECEPTORS, British Journal of Pharmacology, 114, 1995, pp. 2-2
Citation: T. Priestley et Ja. Kemp, KINETIC-STUDY OF THE INTERACTIONS BETWEEN THE GLUTAMATE AND GLYCINE RECOGNITION SITES ON THE N-METHYL-D-ASPARTIC ACID RECEPTOR COMPLEX, Molecular pharmacology, 46(6), 1994, pp. 1191-1196
Citation: T. Priestley et al., IFENPRODIL AND CGS-19755 DISCRIMINATE BETWEEN CORTICAL AND CEREBELLARNMDA RECEPTORS, British Journal of Pharmacology, 112, 1994, pp. 210000102-210000102
Citation: T. Priestley et Ja. Kemp, AGONIST RESPONSE KINETICS OF N-METHYL-D-ASPARTATE RECEPTORS IN NEURONS CULTURED FROM RAT CEREBRAL-CORTEX AND CEREBELLUM - EVIDENCE FOR RECEPTOR HETEROGENEITY, Molecular pharmacology, 44(6), 1993, pp. 1252-1257
Citation: T. Priestley et Ja. Kemp, FUNCTIONAL EVIDENCE FOR DIFFERENT NMDA RECEPTOR SUBTYPES IN NEURONS CULTURED FROM 2 REGIONS OF RAT-BRAIN, Journal of neurochemistry, 61, 1993, pp. 190000257-190000257
Citation: Ja. Kemp et al., DIFFERENCES BETWEEN THE ELECTROPHYSIOLOGICAL PROPERTIES OF 7-CHLOROKYNURENIC ACID AND A NEW GLYCINE-SITE ANTAGONIST, L-695,902, Journal of neurochemistry, 61, 1993, pp. 190000281-190000281